94
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Presarcopenia Is an Independent Risk Factor for Carotid Atherosclerosis in Chinese Population with Metabolic Syndrome

, , , , , , , , & show all
Pages 81-88 | Published online: 09 Jan 2020

References

  • Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S–991S. doi:10.1093/jn/127.5.990S
  • Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19–21, 1988. Am J Clin Nutr. 1989;50(5 Suppl):1121–1235.
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
  • Lancet Diabetes & Endocrinology, T. Sarcopenia: a fate worth challenging. Lancet Diabetes Endocrinol. 2014;2(3):183. doi:10.1016/S2213-8587(14)70055-5
  • O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12. doi:10.1111/obr.12229
  • Collins KH, Herzog W, MacDonald GZ, et al. Obesity, metabolic syndrome, and musculoskeletal disease: common inflammatory pathways suggest a central role for loss of muscle integrity. Front Physiol. 2018;9:112. doi:10.3389/fphys.2018.00112
  • Alberti KG, Zimmet P, Shaw J. The metabolic syndrome–a new worldwide definition. Lancet. 2005;366(9491):1059–1062. doi:10.1016/S0140-6736(05)67402-8
  • Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care. 2005;28(11):2745–2749. doi:10.2337/diacare.28.11.2745
  • Bayturan O, Tuzcu EM, Lavoie A, et al. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med. 2010;170(5):478–484. doi:10.1001/archinternmed.2009.551
  • Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2004;110(18):2952–2967. doi:10.1161/01.CIR.0000145546.97738.1E
  • Oda E. Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol. 2012;49(2):89–95. doi:10.1007/s00592-011-0309-6
  • Zheng N, Wei D, Dai B, et al. Mitochondrial genome encoded proteins expression disorder, the possible mechanism of the heart disease in metabolic syndrome. Cell Physiol Biochem. 2017;43(3):959–968. doi:10.1159/000481649
  • Chung HS, Choi KM. Adipokines and myokines: a pivotal role in metabolic and cardiovascular disorders. Curr Med Chem. 2018;25(20):2401–2415. doi:10.2174/0929867325666171205144627
  • Kim TN, Choi KM. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. J Cell Biochem. 2015;116(7):1171–1178. doi:10.1002/jcb.v116.7
  • Buchmann N, Nikolov J, Spira D, et al. Identifying sarcopenia in metabolic syndrome: data from the berlin aging study II. J Gerontol a Biol Sci Med Sci. 2016;71(2):265–272. doi:10.1093/gerona/glv089
  • Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010;33(7):1652–1654. doi:10.2337/dc10-0107
  • Sanada K, Iemitsu M, Murakami H, et al. Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women. Eur J Clin Nutr. 2012;66(10):1093–1098. doi:10.1038/ejcn.2012.43
  • Liu J, Tse LA, Liu Z, et al. Predictive values of anthropometric measurements for cardiometabolic risk factors and cardiovascular diseases among 44 048 Chinese. J Am Heart Assoc. 2019;8(16):e010870. doi:10.1161/JAHA.118.010870
  • Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–2410. doi:10.1210/jcem.85.7.6661
  • Lee RC, Wang Z, Heo M, Ross R, Janssen I, Heymsfield SB. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr. 2000;72(3):796–803. doi:10.1093/ajcn/72.3.796
  • Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:10.1016/j.jamda.2013.11.025
  • Lee YH, Jung KS, Kim SU, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008–2011). J Hepatol. 2015;63(2):486–493. doi:10.1016/j.jhep.2015.02.051
  • Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889–896. doi:10.1046/j.1532-5415.2002.50216.x
  • Espeland MA, Craven TE, Riley WA, Corson J, Romont A, Furberg CD. Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic carotid artery progression study research group. Stroke. 1996;27(3):480–485. doi:10.1161/01.STR.27.3.480
  • Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21(2):93–111; quiz 189–190. doi:10.1016/j.echo.2007.11.011
  • Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the rotterdam study. Circulation. 1997;96(5):1432–1437. doi:10.1161/01.CIR.96.5.1432
  • Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014;7(10):1025–1038. doi:10.1016/j.jcmg.2013.11.014
  • Gu X, Fang X, Hua Y, et al. Association between kidney dysfunction and carotid atherosclerosis in community-based older adults in China. Angiology. 2016;67(3):252–258. doi:10.1177/0003319715586505
  • Johnson HM, Stein JH. Measurement of carotid intima-media thickness and carotid plaque detection for cardiovascular risk assessment. J Nucl Cardiol. 2011;18(1):153–162. doi:10.1007/s12350-010-9319-y
  • Maher V, O’Dowd M, Carey M, et al. Association of central obesity with early carotid intima-media thickening is independent of that from other risk factors. Int J Obes (Lond). 2009;33(1):136–143. doi:10.1038/ijo.2008.254
  • Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am. 2008;37(3):581–601, vii-viii. doi:10.1016/j.ecl.2008.06.005
  • Johnson ML, Robinson MM, Nair KS. Skeletal muscle aging and the mitochondrion. Trends Endocrinol Metab. 2013;24(5):247–256. doi:10.1016/j.tem.2012.12.003
  • Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67–R81. doi:10.1530/JOE-15-0533
  • Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819–829. doi:10.1016/S2213-8587(14)70034-8
  • Reddy KJ, Singh M, Bangit JR, Batsell RR. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med (Hagerstown). 2010;11(9):633–647. doi:10.2459/JCM.0b013e328333645a
  • Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi:10.1186/s12933-018-0762-4
  • Heo JE, Kim HC, Shim JS, et al. Association of appendicular skeletal muscle mass with carotid intima-media thickness according to body mass index in Korean adults. Epidemiol Health. 2018;40:e2018049. doi:10.4178/epih.e2018049
  • Hida T, Imagama S, Ando K, et al. Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: the Yakumo study. Mod Rheumatol. 2018;28(2):345–350. doi:10.1080/14397595.2017.1349058
  • Abbatecola AM, Chiodini P, Gallo C, et al. Pulse wave velocity is associated with muscle mass decline: health ABC study. Age (Dordr). 2012;34(2):469–478. doi:10.1007/s11357-011-9238-0
  • Campos AM, Moura FA, Santos SN, Freitas WM, Sposito AC. Sarcopenia, but not excess weight or increased caloric intake, is associated with coronary subclinical atherosclerosis in the very elderly. Atherosclerosis. 2017;258:138–144. doi:10.1016/j.atherosclerosis.2017.01.005
  • Kato A, Ishida J, Endo Y, et al. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant. 2011;26(6):1967–1976. doi:10.1093/ndt/gfq652
  • Ochi M, Kohara K, Tabara Y, et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis. 2010;212(1):327–332. doi:10.1016/j.atherosclerosis.2010.05.026
  • Yang EJ, Lim S, Lim JY, Kim KW, Jang HC, Paik NJ. Association between muscle strength and metabolic syndrome in older Korean men and women: the Korean longitudinal study on health and aging. Metabolism. 2012;61(3):317–324. doi:10.1016/j.metabol.2011.07.005